Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 20/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL389011 | 0.90 | GPR119 (0.80) | GPR119CYP2C9KCNH2 | |
| SCHEMBL3174766 | 0.89 | GPR119 (0.80) | GPR119CYP2C9KCNH2 | |
| SCHEMBL3249631 | 0.88 | GPR119 (0.66) | GPR119CYP2C9KCNH2 | |
| SCHEMBL3168213 | 0.88 | GPR119 (0.57) | GPR119CYP2C9KCNH2 | |
| SCHEMBL3160048 | 0.87 | GPR119 (0.52) | GPR119CYP2C9KCNH2 | |
| SCHEMBL3155068 | 0.87 | GPR119 (0.52) | GPR119CYP2C9 | |
| SCHEMBL3161229 | 0.86 | GPR119 (0.64) | GPR119CYP2C9KCNH2 | |
| SCHEMBL3164582 | 0.85 | GPR119 (0.63) | GPR119CYP2C9KCNH2 | |
| SCHEMBL3161505 | 0.85 | GPR119 (0.50) | GPR119CYP2C9 | |
| SCHEMBL3165569 | 0.85 | GPR119 (0.50) | GPR119CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1644357-B9 | TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARM INC (US) | 2010-03-24 | — | — | EP | claimed |
| EP-1644357-B1 | TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARM INC (US) | 2007-12-12 | — | — | EP | claimed |